AGEN - Agenus Inc
IEX Last Trade
5.18
0.190 3.668%
Share volume: 260,155
Last Updated: Fri 30 Aug 2024 09:58:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.99
0.19
3.81%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-03-16 | 2023-05-09 | 2023-08-08 | 2023-11-09 | 2024-03-14 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 456.174 M | 429.019 M | 413.556 M | 412.854 M | 383.593 M | 335.472 M | 313.913 M | 256.559 M | |
| Current Assets | 288.934 M | 251.432 M | 213.122 M | 205.689 M | 170.735 M | 125.550 M | 112.416 M | 60.352 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 31.610 M | 24.379 M | 17.023 M | 15.039 M | 11.542 M | 18.215 M | 10.470 M | 7.020 M | |
| Short Term Investments | 31.610 M | 24.379 M | 17.023 M | 15.039 M | 11.542 M | 18.215 M | 10.470 M | 7.020 M | |
| Total Receivables | 18.994 M | 8.823 M | 2.741 M | 1.417 M | 1.341 M | 1.030 M | 25.836 M | 476.000 K | |
| Current Cash | 238.330 M | 218.230 M | 193.358 M | 189.233 M | 157.852 M | 106.305 M | 76.110 M | 52.856 M | |
| Total Non-current Assets | 167.240 M | 177.587 M | 200.434 M | 207.165 M | 212.858 M | 209.922 M | 201.497 M | 196.207 M | |
| Property Plant Equipment | 88.611 M | 101.030 M | 133.017 M | 140.434 M | 143.358 M | 139.679 M | 133.421 M | 130.330 M | |
| Other Assets | 7.922 M | 7.920 M | 4.453 M | 4.419 M | 9.258 M | 11.062 M | 9.336 M | 7.609 M | |
| Intangible Assets | 7.722 M | 6.877 M | 6.228 M | 5.660 M | 4.986 M | 4.497 M | 4.411 M | 4.230 M | |
| Goodwill | 24.438 M | 23.936 M | 25.467 M | 25.623 M | 24.728 M | 24.666 M | 24.723 M | 24.698 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 456.174 M | 429.019 M | 413.556 M | 412.854 M | 383.593 M | 335.472 M | 313.913 M | 256.559 M | |
| Total liabilities | 452.758 M | 449.404 M | 474.834 M | 471.390 M | 476.788 M | 464.584 M | 474.244 M | 457.989 M | |
| Total current liabilities | 159.723 M | 173.073 M | 188.952 M | 190.898 M | 204.068 M | 198.356 M | 255.897 M | 256.002 M | |
| Accounts Payable | 41.002 M | 39.711 M | 40.939 M | 46.768 M | 52.473 M | 40.871 M | 61.446 M | 50.693 M | |
| Other liabilities | 218.241 M | 203.965 M | 203.596 M | 199.581 M | 181.360 M | 176.522 M | 131.119 M | 129.124 M | |
| Current long term debt | 13.699 M | 13.458 M | 575.000 K | 1.022 M | 622.000 K | 387.000 K | 146.000 K | 13.575 M | |
| Long term debt | 0.000 | 0.000 | 12.584 M | 12.627 M | 12.673 M | 12.720 M | 12.768 M | 0.000 | |
| Other liabilities | 218.241 M | 203.965 M | 203.596 M | 199.581 M | 181.360 M | 176.522 M | 131.119 M | 129.124 M | |
| Minority interest | 10.222 M | 8.549 M | 6.376 M | 5.427 M | 16.434 M | 13.820 M | 11.949 M | 11.107 M | |
| Total Shareholder equity | 3.416 M | -20.385 M | -61.278 M | -58.536 M | -93.195 M | -129.112 M | -160.331 M | -201.430 M | |
| Common stock | 277.033 M | 286.854 M | 304.775 M | 323.134 M | 351.379 M | 378.152 M | 18.945 M | 20.368 M | |
| Retained earnings | -1.585 B | -1.639 B | -1.710 B | -1.778 B | -1.847 B | -1.909 B | -1.956 B | -2.018 B |